pipette
ESEspañol

A model of brain function to predict tau across Alzheimer’s disease and related disorders

Nick Corriveau‐Lecavalier, Gemeng Zhang, Hugo Botha, Leland R Barnard, Heather J. Wiste, Ellen Dicks, Venkatsampath Gogineni, Jeyeon Lee, Irene Sintini, Matthew L. Senjem, Christopher G. Schwarz, Petrice M. Cogswell, Derek Richard Johnson, Jeffrey L. Gunter, Michael G. Kamykowski, Jonathan Graff‐Radford, Vijay K. Ramanan, Julie A. Fields, Mary M. Machulda, Nikki H. Stricker, Bradley F. Boeve, VJ Lowe, Kejal Kantarci, David S. Knopman, Jennifer L. Whitwell, Keith A. Josephs, Ronald Carl Petersen, Clifford R. Jack, David Thomas Jones, or the Alzheimer’s Disease Neuroimaging Initiative

Peer-reviewed journalReal-world use

In the authors' words

Abstract We developed a machine learning framework grounded in a computational model of brain function and FDG-PET imaging to predict Alzheimer’s disease (AD)-type tau across AD and related disorders (ADRD). The model was trained on 1088 research participants spanning normal aging and ADRD with FDG-PET and flortaucipir-PET (FTP-PET). Validation was conducted in: (1) a longitudinal subset of the training cohort ( n = 215), (2) Alzheimer’s Disease Neuroimaging Initiative ( n = 295), and (3) a heretogeneous clinical cohort ( n = 264; n = 28 with FTP-PET). Results showed that the model accurately predicted FTP-PET when applied at the participant-level ( R 2 ~ 0.34-0.71). It performed well in clinical scenarios, including classification of low versus high tau stages (79–95% accuracy) and prediction of tau in a heterogeneous clinical cohort without FTP-PET. These findings advance the understanding of the relationship between neurodegeneration and AD-type tau and provide a framework for estimating AD-type tau across ADRD.

Main resultThe abstract does not state a limitation.

Appeared: Sunday, October 4. Nature Communications. Peer-reviewed journal.

DOI: 10.1038/s41467-026-78300-7